Media release
From:
Health: Cannabis use may affect female fertility
Cannabis use may be associated with an increased rate of egg maturation and number of embryos with an incorrect number of chromosomes according to a retrospective study involving patients undergoing in vitro fertilization (IVF), published in Nature Communications. The findings may help us to understand the potential risk of cannabis use on female fertility.
Exposure to both recreational drugs and clinically used medicines can affect fertility. Prior research has identified potential negative consequences of cannabis use on sperm quality, but the effects on oocytes and embryo formation during IVF are not well understood.
Cyntia Duval and colleagues analysed 1,059 follicular fluid samples from patients undergoing IVF treatment in a retrospective matched case-control cohort. Sixty two samples tested positive for tetrahydrocannabinol (THC, the psychoactive ingredient in cannabis) metabolites indicative of cannabis usage. The authors observed that an increased concentration of THC metabolites was associated with increased oocyte maturation rate and a lower number of embryos with the correct number of chromosomes compared to a matched control group. The authors also carried out laboratory experiments on isolated immature oocytes from 24 consented patients to simulate the potential effects of THC exposure, finding that THC levels comparable to levels seen in the ovaries of the 62 patients above can induce higher error rates in the distribution of chromosomes. Importantly, effects on oocyte maturation rate were only seen using levels of THC higher than the mean concentration observed in the patient cohort.
The findings are limited to a specific type of immature oocyte collected during the IVF process and was not statistically powered to analyse results based on patient age, a known factor in oocyte quality. Additionally, the study was conducted in the laboratory, outside of the human body, and did not investigate the association of cannabis use to pregnancy outcomes. The authors conclude that their results aid our understanding of the sex-specific reproductive consequences of cannabis use and could contribute to more effective and evidence-based patient counselling.
Expert Reaction
These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.
Professor Mark Connor is from the Faculty of Medicine and Health Sciences at Macquarie University
"Human eggs (oocytes) have receptors for cannabinoids made by our body, these receptors can also be activated by THC, the main psychoactive ingredient of Cannabis. This study used realistic concentrations of THC and its breakdown products to explore human oocyte physiology and also examined the outcomes of in vitro fertilization of eggs from people with Cannabis products in their system at the time their eggs were collected. Culturing immature eggs in THC changed the expression levels of some genes in the eggs and THC also affected the number of eggs with normal chromosome numbers at maturation. In the comparison study, patients who had consumed Cannabis around the time of egg collection had about 10% fewer fertilized eggs with a normal chromosome number compared to people who had not consumed Cannabis.
The study suggests that consumption of Cannabis might affect the outcome of IVF. The work did not address the potential effects of Cannabis consumption on natural conception. THC having effects on oocyte physiology is consistent with the presence of receptors for our body’s cannabinoids in the human reproductive system, and we are only beginning to understand the effects of real world Cannabis consumption on human reproduction. This work is an interesting step forward."
Associate Professor Alex Polyakov is a Clinical Associate Professor at the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne and is a Medical Director of Genea Fertility Melbourne
"This study investigated how cannabis, specifically tetrahydrocannabinol (THC), affects female fertility by combining laboratory experiments with a clinical case–control analysis. Researchers measured THC and its metabolites in the follicular fluid of women undergoing IVF. About 6% of samples tested positive, and most of those patients had not disclosed cannabis use. THC exposure was linked to higher oocyte maturation rates but significantly lower embryo euploidy rates (fewer genetically normal embryos).
In laboratory experiments, immature human oocytes exposed to physiologically relevant THC concentrations showed altered gene expression, disruption of the cytoskeleton, abnormal spindle formation, and increased chromosome segregation errors. These biological changes are consistent with a higher risk of producing abnormal embryos. The study therefore provides the first direct evidence that THC can impair egg quality and subsequent embryo development. A key strength of this research is that it not only demonstrates the negative impact of cannabis use on embryo quality but also provides a physiological explanation for this outcome."
Implications for Fertility Patients
"For women considering or undergoing fertility treatment, this research suggests that cannabis use may compromise reproductive outcomes—not by preventing fertilisation, but by reducing the likelihood of producing chromosomally normal embryos. Since embryo euploidy is closely linked to successful implantation and healthy pregnancy, cannabis exposure could prolong the time to conception and increase the risk of IVF failure and miscarriage."
Recommendations
"Based on these findings, fertility specialists should routinely ask about cannabis use, bearing in mind that patients often under-report. Clear, non-judgmental counselling should highlight the potential impact on embryo quality, the increased risk of failure to conceive, and the risk of miscarriage. Patients should be advised to avoid cannabis use while attempting conception or undergoing IVF, as even occasional use may expose oocytes to THC. Educational materials on reproductive health should include cannabis alongside other lifestyle factors such as alcohol, tobacco, and BMI. Larger prospective studies are needed to clarify dose–response effects, the impact of different cannabis preparations, and whether risks extend beyond IVF patients to natural conception."